Exciting news! CAR T-cell therapy was the first gene therapy approved by the FDA. The Centers for Medicare & Medicaid Services (CMS) recently proposed to cover FDA-approved CAR T-cell therapies, thus increasing access to this therapy. Learn more here: buff.ly/2NkydbT

A study recently published in Nature Genetics reported that "Cancer patients with high tumor mutational burden who were treated with immunotherapy tended to live longer than those with fewer mutations." - buff.ly/2H8jYWn #immunotherapy #TMB #tumormutationalburden c

One dose of #Keytruda (#pembrolizumab) before surgery may put melanoma patients' cancer into remission. Learn more: buff.ly/2EAmL99

#Immunotherapy is a biological cancer treatment that helps your immune system fight #cancer. There are several different types of immunotherapies, such as nonspecific immune stimulation, T-cell transfer therapy, and immune checkpoint inhibitors. buff.ly/2KF0qc3

Hereditary and somatic (tumor) testing can play a crucial role in a #cancer patient's treatment plan. Visit myoncopath.com or email [email protected] to connect with one of our cancer #geneticcounselors. #PrecisionMedicine #GeneticTesting #Oncology #CancerTreatment

"New research published in the journal Nature shows that breast cancer is 11 genetically distinct diseases, and each has a different prognosis and chance of coming back after treatment." - buff.ly/2HwE3qp

According to National Cancer Institute, everyone over the age of 50 should be screened for #coloncancer and #rectalcancer. Learn more about screening methods (colonoscopy, sigmoidoscopy, & home stool test) that help reduce the chance of death from colon and rectal cancer : buff.ly/2UfYii3

#Darolutamide, an androgen receptor inhibitor that does not penetrate the blood-brain barrier, can help delay the spread of #prostatecancer. Moreover, darolutamide lacks some of the side effects seen with similar drugs used to treat prostate cancer. - buff.ly/2UfLacP

#Immunotherapies can extend survival beyond 3 years. Combination treatments including an immune checkpoint inhibitor & targeted therapy #axitinib (Inlyta) led to better outcomes for advanced #kidneycancer patients than treatment with #sunitinib alone. - buff.ly/2WoCK0a

Dr. Burris said, “At the top of my list are the cost of cancer care, access to care, how to continue to provide high-quality care with the increasing number of cancer survivors and identifying patients at high risk for cancer.” (buff.ly/2UtAW92) #PrecisionMedicine

"Regional delivery of mesothelin-targeted CARs in combination with an anti–PD-1 agent shows durable responses. This study strongly supports pursuing CAR T-cell therapy combined with anti–PD-1 strategies in solid tumors.” buff.ly/2TVPWrK #PrecisionMedicine #oncology

“The combination of lenvatinib (Lenvima) plus pembrolizumab (Keytruda) showed anti-tumor activity in patients with recurrent advanced endometrial carcinoma – regardless of microsatellite instability or programmed- death ligand 1 (PD-L1) expression status.” buff.ly/2K7kEyx

What is CAR-T therapy? "A treatment that helps the immune system fight deadly blood cancers is showing early signs of promise against some solid tumors, giving hope that this approach might be extended to more common cancers in the future. Learn more: buff.ly/2UeI4Xo

"The estimated percentage of US patients with cancer who are eligible for checkpoint inhibitor drugs increased from 1.54% in 2011 to 43.63% in 2018." - buff.ly/2DMUifJ #PrecisionMedicine #PersonalizedMedicine #PrecisionOncology #CancerTreatment #immunotherapy

What is immunotherapy? How does the immune system fight cancer? Click here for a quick, three-minute animation created by the National Cancer Institute: youtube.com/watch?v=jDdL2b…

An analysis of over 83,000 women from cancer registries in California and Georgia found that only 1/4 of women with breast cancer and 1/3 with ovarian cancer underwent genetic testing for known harmful variants in susceptibility genes. Read more: cancer.gov/news-events/ca…

A new combination therapy for head and neck squamous cell carcinoma (HNSCC) is being investigated in a clinical trial. Birinapant, a novel radiosensitizer, kills cancer cells by promoting signaling pathways that activate natural cell death. Read more:ccr.cancer.gov/news/article/i…

Earlier this year, U.S. FDA expanded use of ado-trastuzumab emtansine (Kadcyla) to treat women with HER2-positive breast cancer. Ado-trastuzumab (T-DM1) was approved by the FDA over 6 years ago to treat metastatic HER2-positive breast cancer. Read more: cancer.gov/news-events/ca…

Bintrafusp alfa is a new immunotherapy drug that has been shown to shrink tumors of some patients with advanced HPV-related cancers. The drug simultaneously binds to PD-L1 and TGF-beta. Read more: cancer.gov/news-events/ca…

This is great news for patients that can benefit from CAR T-cell therapy! CMS: Medicare will begin to cover CAR T-cell therapies in some facilities fiercehealthcare.com/hospitals-heal…